nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—breast cancer	0.319	1	CbGaD
Clodronate—SLC25A4—mammary gland—breast cancer	0.00822	0.0559	CbGeAlD
Clodronate—SLC25A5—nipple—breast cancer	0.00725	0.0493	CbGeAlD
Clodronate—SLC25A6—embryo—breast cancer	0.00688	0.0468	CbGeAlD
Clodronate—SLC25A5—embryo—breast cancer	0.00598	0.0407	CbGeAlD
Clodronate—SLC25A6—epithelium—breast cancer	0.00561	0.0382	CbGeAlD
Clodronate—SLC25A6—skin of body—breast cancer	0.00534	0.0363	CbGeAlD
Clodronate—SLC25A5—epithelium—breast cancer	0.00488	0.0332	CbGeAlD
Clodronate—SLC25A5—skin of body—breast cancer	0.00464	0.0316	CbGeAlD
Clodronate—SLC25A6—uterus—breast cancer	0.00464	0.0316	CbGeAlD
Clodronate—SLC25A6—adipose tissue—breast cancer	0.00454	0.0309	CbGeAlD
Clodronate—SLC25A5—endometrium—breast cancer	0.00438	0.0298	CbGeAlD
Clodronate—SLC25A6—female reproductive system—breast cancer	0.00417	0.0284	CbGeAlD
Clodronate—SLC25A6—adrenal gland—breast cancer	0.00407	0.0277	CbGeAlD
Clodronate—SLC25A5—uterus—breast cancer	0.00404	0.0274	CbGeAlD
Clodronate—SLC25A5—pituitary gland—breast cancer	0.00396	0.027	CbGeAlD
Clodronate—SLC25A6—Vinorelbine—Vinblastine—breast cancer	0.00395	0.588	CbGdCrCtD
Clodronate—SLC25A5—adipose tissue—breast cancer	0.00395	0.0268	CbGeAlD
Clodronate—SLC25A6—bone marrow—breast cancer	0.00394	0.0268	CbGeAlD
Clodronate—SLC25A6—female gonad—breast cancer	0.00379	0.0258	CbGeAlD
Clodronate—SLC25A4—pituitary gland—breast cancer	0.00371	0.0253	CbGeAlD
Clodronate—SLC25A4—adipose tissue—breast cancer	0.0037	0.0252	CbGeAlD
Clodronate—SLC25A5—female reproductive system—breast cancer	0.00363	0.0247	CbGeAlD
Clodronate—SLC25A5—adrenal gland—breast cancer	0.00354	0.0241	CbGeAlD
Clodronate—SLC25A6—endocrine gland—breast cancer	0.00353	0.024	CbGeAlD
Clodronate—SLC25A5—bone marrow—breast cancer	0.00342	0.0233	CbGeAlD
Clodronate—SLC25A4—female reproductive system—breast cancer	0.0034	0.0231	CbGeAlD
Clodronate—SLC25A4—adrenal gland—breast cancer	0.00332	0.0226	CbGeAlD
Clodronate—SLC25A5—female gonad—breast cancer	0.0033	0.0225	CbGeAlD
Clodronate—SLC25A4—female gonad—breast cancer	0.00309	0.021	CbGeAlD
Clodronate—SLC25A5—endocrine gland—breast cancer	0.00307	0.0209	CbGeAlD
Clodronate—SLC25A4—endocrine gland—breast cancer	0.00288	0.0196	CbGeAlD
Clodronate—SLC25A5—Azacitidine—Gemcitabine—breast cancer	0.00277	0.412	CbGdCrCtD
Clodronate—SLC25A6—lymph node—breast cancer	0.00244	0.0166	CbGeAlD
Clodronate—SLC25A5—lymph node—breast cancer	0.00212	0.0144	CbGeAlD
Clodronate—SLC25A4—lymph node—breast cancer	0.00199	0.0135	CbGeAlD
Clodronate—Zoledronate—ABCC1—breast cancer	0.00196	1	CrCbGaD
Clodronate—PTGS2—embryo—breast cancer	0.00113	0.00767	CbGeAlD
Clodronate—PTGS2—epithelium—breast cancer	0.00092	0.00625	CbGeAlD
Clodronate—PTGS2—skin of body—breast cancer	0.000875	0.00595	CbGeAlD
Clodronate—PTGS2—endometrium—breast cancer	0.000825	0.00561	CbGeAlD
Clodronate—PTGS2—uterus—breast cancer	0.00076	0.00517	CbGeAlD
Clodronate—PTGS2—pituitary gland—breast cancer	0.000746	0.00508	CbGeAlD
Clodronate—PTGS2—adipose tissue—breast cancer	0.000743	0.00505	CbGeAlD
Clodronate—PTGS2—female reproductive system—breast cancer	0.000683	0.00465	CbGeAlD
Clodronate—PTGS2—adrenal gland—breast cancer	0.000667	0.00453	CbGeAlD
Clodronate—PTGS2—bone marrow—breast cancer	0.000645	0.00439	CbGeAlD
Clodronate—PTGS2—female gonad—breast cancer	0.000622	0.00423	CbGeAlD
Clodronate—PTGS2—endocrine gland—breast cancer	0.000578	0.00393	CbGeAlD
Clodronate—PTGS2—lymph node—breast cancer	0.0004	0.00272	CbGeAlD
Clodronate—Urticaria—Goserelin—breast cancer	0.000218	0.000689	CcSEcCtD
Clodronate—Abdominal pain—Goserelin—breast cancer	0.000217	0.000686	CcSEcCtD
Clodronate—Renal failure—Docetaxel—breast cancer	0.000216	0.000683	CcSEcCtD
Clodronate—Pneumonia—Capecitabine—breast cancer	0.000214	0.000676	CcSEcCtD
Clodronate—Decreased appetite—Vinorelbine—breast cancer	0.000214	0.000675	CcSEcCtD
Clodronate—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000212	0.000671	CcSEcCtD
Clodronate—Mediastinal disorder—Paclitaxel—breast cancer	0.00021	0.000663	CcSEcCtD
Clodronate—Renal failure—Capecitabine—breast cancer	0.000209	0.000661	CcSEcCtD
Clodronate—Renal failure acute—Epirubicin—breast cancer	0.000208	0.000659	CcSEcCtD
Clodronate—Dyspepsia—Thiotepa—breast cancer	0.000207	0.000653	CcSEcCtD
Clodronate—Vomiting—Chlorambucil—breast cancer	0.000205	0.000649	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000204	0.000647	CcSEcCtD
Clodronate—Decreased appetite—Thiotepa—breast cancer	0.000204	0.000645	CcSEcCtD
Clodronate—Hepatic function abnormal—Doxorubicin—breast cancer	0.000203	0.000644	CcSEcCtD
Clodronate—Pruritus—Tamoxifen—breast cancer	0.000203	0.000643	CcSEcCtD
Clodronate—Gastrointestinal disorder—Thiotepa—breast cancer	0.000203	0.000641	CcSEcCtD
Clodronate—Diarrhoea—Vinblastine—breast cancer	0.000202	0.00064	CcSEcCtD
Clodronate—Renal impairment—Epirubicin—breast cancer	0.000202	0.000639	CcSEcCtD
Clodronate—Infection—Mitoxantrone—breast cancer	0.000201	0.000637	CcSEcCtD
Clodronate—Infection—Irinotecan—breast cancer	0.000201	0.000637	CcSEcCtD
Clodronate—Pruritus—Melphalan—breast cancer	0.000199	0.000629	CcSEcCtD
Clodronate—Cardiac failure—Epirubicin—breast cancer	0.000197	0.000623	CcSEcCtD
Clodronate—Skin disorder—Mitoxantrone—breast cancer	0.000197	0.000622	CcSEcCtD
Clodronate—Diarrhoea—Tamoxifen—breast cancer	0.000196	0.000622	CcSEcCtD
Clodronate—Infection—Gemcitabine—breast cancer	0.000196	0.00062	CcSEcCtD
Clodronate—Pharyngitis—Docetaxel—breast cancer	0.000196	0.000619	CcSEcCtD
Clodronate—Urticaria—Vinorelbine—breast cancer	0.000195	0.000617	CcSEcCtD
Clodronate—Urinary tract disorder—Docetaxel—breast cancer	0.000195	0.000616	CcSEcCtD
Clodronate—Abdominal pain—Vinorelbine—breast cancer	0.000194	0.000614	CcSEcCtD
Clodronate—Pruritus—Goserelin—breast cancer	0.000194	0.000614	CcSEcCtD
Clodronate—Connective tissue disorder—Docetaxel—breast cancer	0.000194	0.000613	CcSEcCtD
Clodronate—Urethral disorder—Docetaxel—breast cancer	0.000193	0.000611	CcSEcCtD
Clodronate—Anorexia—Irinotecan—breast cancer	0.000193	0.000611	CcSEcCtD
Clodronate—Anorexia—Mitoxantrone—breast cancer	0.000193	0.000611	CcSEcCtD
Clodronate—Infection—Fluorouracil—breast cancer	0.000193	0.00061	CcSEcCtD
Clodronate—Renal failure acute—Doxorubicin—breast cancer	0.000193	0.000609	CcSEcCtD
Clodronate—Diarrhoea—Melphalan—breast cancer	0.000192	0.000609	CcSEcCtD
Clodronate—Skin disorder—Gemcitabine—breast cancer	0.000192	0.000606	CcSEcCtD
Clodronate—Nausea—Chlorambucil—breast cancer	0.000192	0.000606	CcSEcCtD
Clodronate—Pharyngitis—Capecitabine—breast cancer	0.000189	0.000599	CcSEcCtD
Clodronate—Urinary tract disorder—Capecitabine—breast cancer	0.000188	0.000596	CcSEcCtD
Clodronate—Anorexia—Gemcitabine—breast cancer	0.000188	0.000595	CcSEcCtD
Clodronate—Vomiting—Vinblastine—breast cancer	0.000188	0.000595	CcSEcCtD
Clodronate—Diarrhoea—Goserelin—breast cancer	0.000188	0.000594	CcSEcCtD
Clodronate—Connective tissue disorder—Capecitabine—breast cancer	0.000188	0.000593	CcSEcCtD
Clodronate—Anaemia—Paclitaxel—breast cancer	0.000187	0.000592	CcSEcCtD
Clodronate—Urethral disorder—Capecitabine—breast cancer	0.000187	0.000592	CcSEcCtD
Clodronate—Renal impairment—Doxorubicin—breast cancer	0.000187	0.000591	CcSEcCtD
Clodronate—Urticaria—Thiotepa—breast cancer	0.000186	0.00059	CcSEcCtD
Clodronate—Abdominal pain—Thiotepa—breast cancer	0.000185	0.000587	CcSEcCtD
Clodronate—Angioedema—Paclitaxel—breast cancer	0.000185	0.000585	CcSEcCtD
Clodronate—Anorexia—Fluorouracil—breast cancer	0.000185	0.000585	CcSEcCtD
Clodronate—Vomiting—Tamoxifen—breast cancer	0.000183	0.000578	CcSEcCtD
Clodronate—Cardiac failure—Doxorubicin—breast cancer	0.000182	0.000576	CcSEcCtD
Clodronate—Rash—Tamoxifen—breast cancer	0.000181	0.000573	CcSEcCtD
Clodronate—Dermatitis—Tamoxifen—breast cancer	0.000181	0.000572	CcSEcCtD
Clodronate—Dyspnoea—Irinotecan—breast cancer	0.000181	0.000571	CcSEcCtD
Clodronate—Dyspnoea—Mitoxantrone—breast cancer	0.000181	0.000571	CcSEcCtD
Clodronate—Blood creatinine increased—Epirubicin—breast cancer	0.00018	0.00057	CcSEcCtD
Clodronate—Vomiting—Melphalan—breast cancer	0.000179	0.000566	CcSEcCtD
Clodronate—Dehydration—Epirubicin—breast cancer	0.000179	0.000565	CcSEcCtD
Clodronate—Dyspepsia—Mitoxantrone—breast cancer	0.000178	0.000564	CcSEcCtD
Clodronate—Dyspepsia—Irinotecan—breast cancer	0.000178	0.000564	CcSEcCtD
Clodronate—Mediastinal disorder—Docetaxel—breast cancer	0.000178	0.000562	CcSEcCtD
Clodronate—Rash—Melphalan—breast cancer	0.000177	0.000561	CcSEcCtD
Clodronate—Dermatitis—Melphalan—breast cancer	0.000177	0.00056	CcSEcCtD
Clodronate—Decreased appetite—Mitoxantrone—breast cancer	0.000176	0.000557	CcSEcCtD
Clodronate—Decreased appetite—Irinotecan—breast cancer	0.000176	0.000557	CcSEcCtD
Clodronate—Dyspnoea—Gemcitabine—breast cancer	0.000176	0.000557	CcSEcCtD
Clodronate—Nausea—Vinblastine—breast cancer	0.000176	0.000555	CcSEcCtD
Clodronate—Abdominal pain upper—Epirubicin—breast cancer	0.000176	0.000555	CcSEcCtD
Clodronate—Gastrointestinal disorder—Irinotecan—breast cancer	0.000175	0.000553	CcSEcCtD
Clodronate—Vomiting—Goserelin—breast cancer	0.000174	0.000552	CcSEcCtD
Clodronate—Pruritus—Vinorelbine—breast cancer	0.000174	0.00055	CcSEcCtD
Clodronate—Dyspnoea—Fluorouracil—breast cancer	0.000173	0.000547	CcSEcCtD
Clodronate—Rash—Goserelin—breast cancer	0.000173	0.000547	CcSEcCtD
Clodronate—Dermatitis—Goserelin—breast cancer	0.000173	0.000547	CcSEcCtD
Clodronate—Mediastinal disorder—Capecitabine—breast cancer	0.000172	0.000544	CcSEcCtD
Clodronate—Decreased appetite—Gemcitabine—breast cancer	0.000172	0.000543	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000171	0.000541	CcSEcCtD
Clodronate—Dyspepsia—Fluorouracil—breast cancer	0.000171	0.00054	CcSEcCtD
Clodronate—Nausea—Tamoxifen—breast cancer	0.000171	0.00054	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gemcitabine—breast cancer	0.00017	0.000539	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Epirubicin—breast cancer	0.00017	0.000536	CcSEcCtD
Clodronate—Decreased appetite—Fluorouracil—breast cancer	0.000169	0.000534	CcSEcCtD
Clodronate—Diarrhoea—Vinorelbine—breast cancer	0.000168	0.000532	CcSEcCtD
Clodronate—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000168	0.00053	CcSEcCtD
Clodronate—Nausea—Melphalan—breast cancer	0.000167	0.000528	CcSEcCtD
Clodronate—Blood creatinine increased—Doxorubicin—breast cancer	0.000167	0.000527	CcSEcCtD
Clodronate—Dysphagia—Epirubicin—breast cancer	0.000166	0.000525	CcSEcCtD
Clodronate—Pruritus—Thiotepa—breast cancer	0.000166	0.000525	CcSEcCtD
Clodronate—Dehydration—Doxorubicin—breast cancer	0.000165	0.000523	CcSEcCtD
Clodronate—Infection—Paclitaxel—breast cancer	0.000164	0.000519	CcSEcCtD
Clodronate—Nausea—Goserelin—breast cancer	0.000163	0.000515	CcSEcCtD
Clodronate—Abdominal pain upper—Doxorubicin—breast cancer	0.000162	0.000514	CcSEcCtD
Clodronate—Urticaria—Mitoxantrone—breast cancer	0.000161	0.000509	CcSEcCtD
Clodronate—Diarrhoea—Thiotepa—breast cancer	0.000161	0.000508	CcSEcCtD
Clodronate—Skin disorder—Paclitaxel—breast cancer	0.00016	0.000508	CcSEcCtD
Clodronate—Abdominal pain—Mitoxantrone—breast cancer	0.00016	0.000507	CcSEcCtD
Clodronate—Abdominal pain—Irinotecan—breast cancer	0.00016	0.000507	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—breast cancer	0.000159	0.000504	CcSEcCtD
Clodronate—Anaemia—Docetaxel—breast cancer	0.000159	0.000502	CcSEcCtD
Clodronate—Anorexia—Paclitaxel—breast cancer	0.000158	0.000498	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000157	0.000496	CcSEcCtD
Clodronate—Vomiting—Vinorelbine—breast cancer	0.000156	0.000494	CcSEcCtD
Clodronate—Renal failure—Methotrexate—breast cancer	0.000156	0.000492	CcSEcCtD
Clodronate—Rash—Vinorelbine—breast cancer	0.000155	0.00049	CcSEcCtD
Clodronate—Dermatitis—Vinorelbine—breast cancer	0.000155	0.000489	CcSEcCtD
Clodronate—Urticaria—Fluorouracil—breast cancer	0.000154	0.000488	CcSEcCtD
Clodronate—Dysphagia—Doxorubicin—breast cancer	0.000154	0.000486	CcSEcCtD
Clodronate—Anaemia—Capecitabine—breast cancer	0.000154	0.000486	CcSEcCtD
Clodronate—Vomiting—Thiotepa—breast cancer	0.000149	0.000472	CcSEcCtD
Clodronate—Pneumonia—Epirubicin—breast cancer	0.000149	0.000471	CcSEcCtD
Clodronate—Rash—Thiotepa—breast cancer	0.000148	0.000468	CcSEcCtD
Clodronate—Dermatitis—Thiotepa—breast cancer	0.000148	0.000467	CcSEcCtD
Clodronate—Dyspnoea—Paclitaxel—breast cancer	0.000147	0.000466	CcSEcCtD
Clodronate—Nausea—Vinorelbine—breast cancer	0.000146	0.000462	CcSEcCtD
Clodronate—Renal failure—Epirubicin—breast cancer	0.000146	0.000461	CcSEcCtD
Clodronate—Dyspepsia—Paclitaxel—breast cancer	0.000145	0.00046	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000145	0.000459	CcSEcCtD
Clodronate—Decreased appetite—Paclitaxel—breast cancer	0.000144	0.000454	CcSEcCtD
Clodronate—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000143	0.000451	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—breast cancer	0.000141	0.000446	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00014	0.000444	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—breast cancer	0.00014	0.000444	CcSEcCtD
Clodronate—Pruritus—Gemcitabine—breast cancer	0.00014	0.000442	CcSEcCtD
Clodronate—Nausea—Thiotepa—breast cancer	0.000139	0.000441	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—breast cancer	0.000139	0.000441	CcSEcCtD
Clodronate—Infection—Docetaxel—breast cancer	0.000139	0.00044	CcSEcCtD
Clodronate—Diarrhoea—Mitoxantrone—breast cancer	0.000139	0.000438	CcSEcCtD
Clodronate—Diarrhoea—Irinotecan—breast cancer	0.000139	0.000438	CcSEcCtD
Clodronate—Pneumonia—Doxorubicin—breast cancer	0.000138	0.000436	CcSEcCtD
Clodronate—Pruritus—Fluorouracil—breast cancer	0.000137	0.000434	CcSEcCtD
Clodronate—Skin disorder—Docetaxel—breast cancer	0.000136	0.00043	CcSEcCtD
Clodronate—Diarrhoea—Gemcitabine—breast cancer	0.000135	0.000427	CcSEcCtD
Clodronate—Renal failure—Doxorubicin—breast cancer	0.000135	0.000426	CcSEcCtD
Clodronate—Infection—Capecitabine—breast cancer	0.000135	0.000426	CcSEcCtD
Clodronate—Anorexia—Docetaxel—breast cancer	0.000133	0.000422	CcSEcCtD
Clodronate—Diarrhoea—Fluorouracil—breast cancer	0.000133	0.00042	CcSEcCtD
Clodronate—Pharyngitis—Epirubicin—breast cancer	0.000132	0.000417	CcSEcCtD
Clodronate—Skin disorder—Capecitabine—breast cancer	0.000132	0.000417	CcSEcCtD
Clodronate—Urinary tract disorder—Epirubicin—breast cancer	0.000131	0.000415	CcSEcCtD
Clodronate—Urticaria—Paclitaxel—breast cancer	0.000131	0.000415	CcSEcCtD
Clodronate—Connective tissue disorder—Epirubicin—breast cancer	0.000131	0.000413	CcSEcCtD
Clodronate—Abdominal pain—Paclitaxel—breast cancer	0.000131	0.000413	CcSEcCtD
Clodronate—Urethral disorder—Epirubicin—breast cancer	0.00013	0.000412	CcSEcCtD
Clodronate—Anorexia—Capecitabine—breast cancer	0.000129	0.000409	CcSEcCtD
Clodronate—Vomiting—Mitoxantrone—breast cancer	0.000129	0.000407	CcSEcCtD
Clodronate—Vomiting—Irinotecan—breast cancer	0.000129	0.000407	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—breast cancer	0.000128	0.000405	CcSEcCtD
Clodronate—Rash—Mitoxantrone—breast cancer	0.000128	0.000404	CcSEcCtD
Clodronate—Rash—Irinotecan—breast cancer	0.000128	0.000404	CcSEcCtD
Clodronate—Dermatitis—Mitoxantrone—breast cancer	0.000128	0.000404	CcSEcCtD
Clodronate—Dermatitis—Irinotecan—breast cancer	0.000128	0.000404	CcSEcCtD
Clodronate—Vomiting—Gemcitabine—breast cancer	0.000125	0.000397	CcSEcCtD
Clodronate—Dyspnoea—Docetaxel—breast cancer	0.000125	0.000395	CcSEcCtD
Clodronate—Rash—Gemcitabine—breast cancer	0.000124	0.000394	CcSEcCtD
Clodronate—Dermatitis—Gemcitabine—breast cancer	0.000124	0.000393	CcSEcCtD
Clodronate—Vomiting—Fluorouracil—breast cancer	0.000123	0.00039	CcSEcCtD
Clodronate—Dyspepsia—Docetaxel—breast cancer	0.000123	0.00039	CcSEcCtD
Clodronate—Rash—Fluorouracil—breast cancer	0.000122	0.000387	CcSEcCtD
Clodronate—Dermatitis—Fluorouracil—breast cancer	0.000122	0.000387	CcSEcCtD
Clodronate—Pharyngitis—Doxorubicin—breast cancer	0.000122	0.000386	CcSEcCtD
Clodronate—Decreased appetite—Docetaxel—breast cancer	0.000122	0.000385	CcSEcCtD
Clodronate—Urinary tract disorder—Doxorubicin—breast cancer	0.000121	0.000384	CcSEcCtD
Clodronate—Gastrointestinal disorder—Docetaxel—breast cancer	0.000121	0.000382	CcSEcCtD
Clodronate—Connective tissue disorder—Doxorubicin—breast cancer	0.000121	0.000382	CcSEcCtD
Clodronate—Dyspnoea—Capecitabine—breast cancer	0.000121	0.000382	CcSEcCtD
Clodronate—Urethral disorder—Doxorubicin—breast cancer	0.000121	0.000381	CcSEcCtD
Clodronate—Nausea—Mitoxantrone—breast cancer	0.00012	0.000381	CcSEcCtD
Clodronate—Nausea—Irinotecan—breast cancer	0.00012	0.000381	CcSEcCtD
Clodronate—Mediastinal disorder—Epirubicin—breast cancer	0.00012	0.000379	CcSEcCtD
Clodronate—Dyspepsia—Capecitabine—breast cancer	0.000119	0.000378	CcSEcCtD
Clodronate—Decreased appetite—Capecitabine—breast cancer	0.000118	0.000373	CcSEcCtD
Clodronate—Nausea—Gemcitabine—breast cancer	0.000117	0.000371	CcSEcCtD
Clodronate—Gastrointestinal disorder—Capecitabine—breast cancer	0.000117	0.00037	CcSEcCtD
Clodronate—Pruritus—Paclitaxel—breast cancer	0.000117	0.00037	CcSEcCtD
Clodronate—Nausea—Fluorouracil—breast cancer	0.000115	0.000365	CcSEcCtD
Clodronate—Anaemia—Methotrexate—breast cancer	0.000114	0.000362	CcSEcCtD
Clodronate—Diarrhoea—Paclitaxel—breast cancer	0.000113	0.000358	CcSEcCtD
Clodronate—Mediastinal disorder—Doxorubicin—breast cancer	0.000111	0.000351	CcSEcCtD
Clodronate—Abdominal pain—Docetaxel—breast cancer	0.000111	0.00035	CcSEcCtD
Clodronate—Urticaria—Capecitabine—breast cancer	0.000108	0.000341	CcSEcCtD
Clodronate—Abdominal pain—Capecitabine—breast cancer	0.000107	0.000339	CcSEcCtD
Clodronate—Anaemia—Epirubicin—breast cancer	0.000107	0.000338	CcSEcCtD
Clodronate—Vomiting—Paclitaxel—breast cancer	0.000105	0.000332	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000105	0.000331	CcSEcCtD
Clodronate—Rash—Paclitaxel—breast cancer	0.000104	0.00033	CcSEcCtD
Clodronate—Dermatitis—Paclitaxel—breast cancer	0.000104	0.000329	CcSEcCtD
Clodronate—Infection—Methotrexate—breast cancer	0.0001	0.000317	CcSEcCtD
Clodronate—Pruritus—Docetaxel—breast cancer	9.91e-05	0.000313	CcSEcCtD
Clodronate—Anaemia—Doxorubicin—breast cancer	9.9e-05	0.000313	CcSEcCtD
Clodronate—Nausea—Paclitaxel—breast cancer	9.81e-05	0.00031	CcSEcCtD
Clodronate—Skin disorder—Methotrexate—breast cancer	9.8e-05	0.00031	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.79e-05	0.00031	CcSEcCtD
Clodronate—Anorexia—Methotrexate—breast cancer	9.62e-05	0.000304	CcSEcCtD
Clodronate—Pruritus—Capecitabine—breast cancer	9.59e-05	0.000303	CcSEcCtD
Clodronate—Diarrhoea—Docetaxel—breast cancer	9.58e-05	0.000303	CcSEcCtD
Clodronate—Infection—Epirubicin—breast cancer	9.38e-05	0.000297	CcSEcCtD
Clodronate—Diarrhoea—Capecitabine—breast cancer	9.28e-05	0.000293	CcSEcCtD
Clodronate—Skin disorder—Epirubicin—breast cancer	9.18e-05	0.00029	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.05e-05	0.000286	CcSEcCtD
Clodronate—Anorexia—Epirubicin—breast cancer	9e-05	0.000285	CcSEcCtD
Clodronate—Dyspnoea—Methotrexate—breast cancer	9e-05	0.000285	CcSEcCtD
Clodronate—Vomiting—Docetaxel—breast cancer	8.9e-05	0.000282	CcSEcCtD
Clodronate—Dyspepsia—Methotrexate—breast cancer	8.89e-05	0.000281	CcSEcCtD
Clodronate—Rash—Docetaxel—breast cancer	8.83e-05	0.000279	CcSEcCtD
Clodronate—Dermatitis—Docetaxel—breast cancer	8.82e-05	0.000279	CcSEcCtD
Clodronate—Decreased appetite—Methotrexate—breast cancer	8.77e-05	0.000278	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methotrexate—breast cancer	8.71e-05	0.000276	CcSEcCtD
Clodronate—Infection—Doxorubicin—breast cancer	8.68e-05	0.000275	CcSEcCtD
Clodronate—Vomiting—Capecitabine—breast cancer	8.62e-05	0.000273	CcSEcCtD
Clodronate—Rash—Capecitabine—breast cancer	8.55e-05	0.00027	CcSEcCtD
Clodronate—Dermatitis—Capecitabine—breast cancer	8.54e-05	0.00027	CcSEcCtD
Clodronate—Skin disorder—Doxorubicin—breast cancer	8.49e-05	0.000269	CcSEcCtD
Clodronate—Dyspnoea—Epirubicin—breast cancer	8.42e-05	0.000266	CcSEcCtD
Clodronate—Anorexia—Doxorubicin—breast cancer	8.33e-05	0.000264	CcSEcCtD
Clodronate—Nausea—Docetaxel—breast cancer	8.32e-05	0.000263	CcSEcCtD
Clodronate—Dyspepsia—Epirubicin—breast cancer	8.32e-05	0.000263	CcSEcCtD
Clodronate—Decreased appetite—Epirubicin—breast cancer	8.21e-05	0.00026	CcSEcCtD
Clodronate—Gastrointestinal disorder—Epirubicin—breast cancer	8.16e-05	0.000258	CcSEcCtD
Clodronate—Nausea—Capecitabine—breast cancer	8.05e-05	0.000255	CcSEcCtD
Clodronate—Urticaria—Methotrexate—breast cancer	8.02e-05	0.000254	CcSEcCtD
Clodronate—Abdominal pain—Methotrexate—breast cancer	7.98e-05	0.000252	CcSEcCtD
Clodronate—Dyspnoea—Doxorubicin—breast cancer	7.79e-05	0.000246	CcSEcCtD
Clodronate—Dyspepsia—Doxorubicin—breast cancer	7.69e-05	0.000243	CcSEcCtD
Clodronate—Decreased appetite—Doxorubicin—breast cancer	7.6e-05	0.00024	CcSEcCtD
Clodronate—Gastrointestinal disorder—Doxorubicin—breast cancer	7.55e-05	0.000239	CcSEcCtD
Clodronate—Urticaria—Epirubicin—breast cancer	7.5e-05	0.000237	CcSEcCtD
Clodronate—Abdominal pain—Epirubicin—breast cancer	7.47e-05	0.000236	CcSEcCtD
Clodronate—Pruritus—Methotrexate—breast cancer	7.14e-05	0.000226	CcSEcCtD
Clodronate—Urticaria—Doxorubicin—breast cancer	6.94e-05	0.00022	CcSEcCtD
Clodronate—Abdominal pain—Doxorubicin—breast cancer	6.91e-05	0.000219	CcSEcCtD
Clodronate—Diarrhoea—Methotrexate—breast cancer	6.91e-05	0.000218	CcSEcCtD
Clodronate—Pruritus—Epirubicin—breast cancer	6.68e-05	0.000211	CcSEcCtD
Clodronate—Diarrhoea—Epirubicin—breast cancer	6.46e-05	0.000204	CcSEcCtD
Clodronate—Vomiting—Methotrexate—breast cancer	6.42e-05	0.000203	CcSEcCtD
Clodronate—Rash—Methotrexate—breast cancer	6.36e-05	0.000201	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—breast cancer	6.36e-05	0.000201	CcSEcCtD
Clodronate—Pruritus—Doxorubicin—breast cancer	6.18e-05	0.000196	CcSEcCtD
Clodronate—Vomiting—Epirubicin—breast cancer	6.01e-05	0.00019	CcSEcCtD
Clodronate—Nausea—Methotrexate—breast cancer	6e-05	0.00019	CcSEcCtD
Clodronate—Diarrhoea—Doxorubicin—breast cancer	5.98e-05	0.000189	CcSEcCtD
Clodronate—Rash—Epirubicin—breast cancer	5.96e-05	0.000188	CcSEcCtD
Clodronate—Dermatitis—Epirubicin—breast cancer	5.95e-05	0.000188	CcSEcCtD
Clodronate—Nausea—Epirubicin—breast cancer	5.61e-05	0.000177	CcSEcCtD
Clodronate—Vomiting—Doxorubicin—breast cancer	5.56e-05	0.000176	CcSEcCtD
Clodronate—Rash—Doxorubicin—breast cancer	5.51e-05	0.000174	CcSEcCtD
Clodronate—Dermatitis—Doxorubicin—breast cancer	5.51e-05	0.000174	CcSEcCtD
Clodronate—Nausea—Doxorubicin—breast cancer	5.19e-05	0.000164	CcSEcCtD
Clodronate—SLC25A6—Disease—MYC—breast cancer	3.43e-05	0.000164	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—breast cancer	3.43e-05	0.000164	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—breast cancer	3.42e-05	0.000164	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	3.41e-05	0.000163	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APRT—breast cancer	3.41e-05	0.000163	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	3.4e-05	0.000163	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—breast cancer	3.39e-05	0.000162	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	3.37e-05	0.000161	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—breast cancer	3.36e-05	0.000161	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.35e-05	0.00016	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.33e-05	0.00016	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—breast cancer	3.33e-05	0.00016	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CTNNB1—breast cancer	3.31e-05	0.000158	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—breast cancer	3.27e-05	0.000156	CbGpPWpGaD
Clodronate—PTGS2—Disease—SFRP2—breast cancer	3.26e-05	0.000156	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPL31—breast cancer	3.26e-05	0.000156	CbGpPWpGaD
Clodronate—PTGS2—Disease—LDHB—breast cancer	3.26e-05	0.000156	CbGpPWpGaD
Clodronate—PTGS2—Disease—HPSE—breast cancer	3.26e-05	0.000156	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1A—breast cancer	3.23e-05	0.000155	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTEN—breast cancer	3.22e-05	0.000154	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HRAS—breast cancer	3.22e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ESRRA—breast cancer	3.21e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ANGPTL4—breast cancer	3.21e-05	0.000154	CbGpPWpGaD
Clodronate—SLC25A6—Disease—KRAS—breast cancer	3.17e-05	0.000152	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CB—breast cancer	3.13e-05	0.00015	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	3.12e-05	0.000149	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—breast cancer	3.1e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Disease—HMMR—breast cancer	3.09e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Disease—VCP—breast cancer	3.09e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Disease—ABCC1—breast cancer	3.09e-05	0.000148	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—breast cancer	3.08e-05	0.000147	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	3.06e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.05e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPI—breast cancer	3.04e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HADHB—breast cancer	3.04e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS4X—breast cancer	3.04e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFBI—breast cancer	3.04e-05	0.000145	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SRC—breast cancer	2.99e-05	0.000143	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	2.97e-05	0.000142	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	2.97e-05	0.000142	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	2.95e-05	0.000141	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CA—breast cancer	2.91e-05	0.000139	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CA—breast cancer	2.91e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.91e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Disease—ELL—breast cancer	2.9e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDH7A1—breast cancer	2.9e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDH1A1—breast cancer	2.9e-05	0.000139	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—breast cancer	2.88e-05	0.000138	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—breast cancer	2.88e-05	0.000138	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	2.88e-05	0.000138	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	2.87e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.87e-05	0.000137	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—breast cancer	2.84e-05	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	2.81e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PHGDH—breast cancer	2.78e-05	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UMPS—breast cancer	2.78e-05	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADSL—breast cancer	2.78e-05	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NME1—breast cancer	2.78e-05	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FHL2—breast cancer	2.78e-05	0.000133	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MAPK3—breast cancer	2.76e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HPSE—breast cancer	2.73e-05	0.000131	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BRIP1—breast cancer	2.73e-05	0.000131	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LDHB—breast cancer	2.73e-05	0.000131	CbGpPWpGaD
Clodronate—PTGS2—Disease—HEY2—breast cancer	2.72e-05	0.00013	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTEN—breast cancer	2.7e-05	0.000129	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HRAS—breast cancer	2.7e-05	0.000129	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS6KB2—breast cancer	2.69e-05	0.000129	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—breast cancer	2.68e-05	0.000128	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—breast cancer	2.67e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.66e-05	0.000127	CbGpPWpGaD
Clodronate—PTGS2—Disease—IDH1—breast cancer	2.66e-05	0.000127	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—breast cancer	2.64e-05	0.000126	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—breast cancer	2.62e-05	0.000125	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	2.59e-05	0.000124	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMMR—breast cancer	2.59e-05	0.000124	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA3—breast cancer	2.59e-05	0.000124	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCC1—breast cancer	2.59e-05	0.000124	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—breast cancer	2.58e-05	0.000124	CbGpPWpGaD
Clodronate—PTGS2—Disease—TLE3—breast cancer	2.54e-05	0.000122	CbGpPWpGaD
Clodronate—PTGS2—Disease—HEY1—breast cancer	2.52e-05	0.00012	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARGC1B—breast cancer	2.5e-05	0.00012	CbGpPWpGaD
Clodronate—SLC25A4—Disease—KRAS—breast cancer	2.48e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPL23A—breast cancer	2.47e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Disease—DLL1—breast cancer	2.47e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.45e-05	0.000117	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CA—breast cancer	2.44e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.44e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.44e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAP2K7—breast cancer	2.42e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIST1H2BK—breast cancer	2.42e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIST1H2BC—breast cancer	2.42e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.39e-05	0.000114	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—breast cancer	2.38e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.38e-05	0.000114	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—breast cancer	2.38e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA4—breast cancer	2.36e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA9—breast cancer	2.36e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.34e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.33e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.31e-05	0.000111	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA2—breast cancer	2.3e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX2—breast cancer	2.3e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS8—breast cancer	2.3e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS7—breast cancer	2.3e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Disease—DKK1—breast cancer	2.28e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SULT1A1—breast cancer	2.28e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX4—breast cancer	2.28e-05	0.000109	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CA—breast cancer	2.27e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Disease—ALDOA—breast cancer	2.27e-05	0.000108	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAG2—breast cancer	2.23e-05	0.000107	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—IDH1—breast cancer	2.22e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA1—breast cancer	2.22e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.22e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.2e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Disease—WNT1—breast cancer	2.2e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NAT2—breast cancer	2.2e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A2—breast cancer	2.18e-05	0.000105	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTR—breast cancer	2.14e-05	0.000102	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HRAS—breast cancer	2.1e-05	0.000101	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.03e-05	9.69e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—breast cancer	2.01e-05	9.64e-05	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—breast cancer	1.99e-05	9.54e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSPA1B—breast cancer	1.99e-05	9.52e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.99e-05	9.51e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.96e-05	9.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DPYD—breast cancer	1.93e-05	9.23e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MED12—breast cancer	1.93e-05	9.23e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO1—breast cancer	1.91e-05	9.13e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CA—breast cancer	1.91e-05	9.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDOA—breast cancer	1.9e-05	9.08e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—breast cancer	1.86e-05	8.89e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA3—breast cancer	1.84e-05	8.82e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A2—breast cancer	1.83e-05	8.76e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.81e-05	8.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF3—breast cancer	1.8e-05	8.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CPT1A—breast cancer	1.79e-05	8.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCG2—breast cancer	1.79e-05	8.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTR—breast cancer	1.79e-05	8.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FASN—breast cancer	1.78e-05	8.52e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAG1—breast cancer	1.78e-05	8.52e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PARP1—breast cancer	1.77e-05	8.49e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HPGDS—breast cancer	1.76e-05	8.41e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALCA—breast cancer	1.75e-05	8.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HBA1—breast cancer	1.75e-05	8.36e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS6—breast cancer	1.73e-05	8.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF4—breast cancer	1.72e-05	8.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CXCR4—breast cancer	1.71e-05	8.19e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTT1—breast cancer	1.7e-05	8.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACHE—breast cancer	1.7e-05	8.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A1—breast cancer	1.69e-05	8.1e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.65e-05	7.92e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TCF7L2—breast cancer	1.65e-05	7.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP17A1—breast cancer	1.61e-05	7.72e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTGS1—breast cancer	1.6e-05	7.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO1—breast cancer	1.6e-05	7.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.59e-05	7.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSP90AA1—breast cancer	1.59e-05	7.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.57e-05	7.52e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2D6—breast cancer	1.57e-05	7.5e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—breast cancer	1.56e-05	7.45e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRL—breast cancer	1.55e-05	7.41e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA2—breast cancer	1.54e-05	7.36e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADAM10—breast cancer	1.52e-05	7.3e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FASN—breast cancer	1.49e-05	7.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BCHE—breast cancer	1.49e-05	7.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF10—breast cancer	1.48e-05	7.1e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC5A5—breast cancer	1.47e-05	7.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFA—breast cancer	1.43e-05	6.85e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NQO1—breast cancer	1.42e-05	6.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A1—breast cancer	1.42e-05	6.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFBR2—breast cancer	1.41e-05	6.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ITPR1—breast cancer	1.39e-05	6.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.39e-05	6.64e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP3A4—breast cancer	1.38e-05	6.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB4—breast cancer	1.38e-05	6.6e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT5A—breast cancer	1.38e-05	6.6e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1B1—breast cancer	1.36e-05	6.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SMAD4—breast cancer	1.34e-05	6.39e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSP90AA1—breast cancer	1.33e-05	6.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HES1—breast cancer	1.3e-05	6.24e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCOR1—breast cancer	1.3e-05	6.21e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA1—breast cancer	1.3e-05	6.2e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF1—breast cancer	1.28e-05	6.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP19A1—breast cancer	1.28e-05	6.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STK11—breast cancer	1.28e-05	6.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NRG1—breast cancer	1.27e-05	6.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—H2AFX—breast cancer	1.26e-05	6.05e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERCC2—breast cancer	1.22e-05	5.84e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.2e-05	5.74e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB3—breast cancer	1.19e-05	5.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGFR2—breast cancer	1.19e-05	5.7e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—COMT—breast cancer	1.19e-05	5.68e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTP1—breast cancer	1.18e-05	5.66e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—breast cancer	1.17e-05	5.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ITPR1—breast cancer	1.16e-05	5.57e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—breast cancer	1.15e-05	5.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TERT—breast cancer	1.14e-05	5.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—breast cancer	1.12e-05	5.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGFR1—breast cancer	1.11e-05	5.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TYMS—breast cancer	1.1e-05	5.26e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIF1A—breast cancer	1.09e-05	5.23e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLA2G4A—breast cancer	1.09e-05	5.2e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOR1—breast cancer	1.09e-05	5.2e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—breast cancer	1.09e-05	5.2e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CAV1—breast cancer	1.06e-05	5.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—breast cancer	1.04e-05	4.98e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1A1—breast cancer	1.03e-05	4.93e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ERCC2—breast cancer	1.02e-05	4.89e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—breast cancer	9.94e-06	4.76e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOTCH1—breast cancer	9.85e-06	4.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APC—breast cancer	9.63e-06	4.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KIT—breast cancer	9.63e-06	4.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—breast cancer	9.6e-06	4.59e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGF—breast cancer	9.52e-06	4.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—BRAF—breast cancer	9.05e-06	4.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAV1—breast cancer	8.85e-06	4.24e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT2—breast cancer	8.81e-06	4.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CD—breast cancer	8.46e-06	4.05e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.46e-06	4.05e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SERPINE1—breast cancer	8.37e-06	4.01e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CG—breast cancer	8.06e-06	3.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—breast cancer	7.99e-06	3.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MDM2—breast cancer	7.58e-06	3.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—RAF1—breast cancer	7.56e-06	3.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB2—breast cancer	7.48e-06	3.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CB—breast cancer	7.38e-06	3.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTOR—breast cancer	7.38e-06	3.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD4—breast cancer	7.36e-06	3.52e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CD—breast cancer	7.09e-06	3.39e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—breast cancer	7e-06	3.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1B—breast cancer	6.92e-06	3.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—breast cancer	6.69e-06	3.2e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CTNNB1—breast cancer	6.54e-06	3.13e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1A—breast cancer	6.39e-06	3.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTEN—breast cancer	6.37e-06	3.05e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CB—breast cancer	6.18e-06	2.96e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SRC—breast cancer	5.91e-06	2.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—breast cancer	5.7e-06	2.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MAPK3—breast cancer	5.45e-06	2.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTEN—breast cancer	5.34e-06	2.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—breast cancer	5.3e-06	2.54e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—breast cancer	5.28e-06	2.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—breast cancer	5.18e-06	2.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—KRAS—breast cancer	4.9e-06	2.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CA—breast cancer	4.5e-06	2.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HRAS—breast cancer	4.16e-06	1.99e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—breast cancer	3.98e-06	1.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CA—breast cancer	3.77e-06	1.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—breast cancer	3.67e-06	1.76e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—breast cancer	3.08e-06	1.47e-05	CbGpPWpGaD
